Prospective randomized, multicenter Phase III Study to assess the
efficacy of partial-body hyperthermia with standardized chemotherapy
in patients with recurrent ovarian cancer

Studienleiter: T. Fehm und V. Heinrich (Tübingen)

Adjuvant instillation with Mitomycin C combined with deep regional
hyperthermia in low risk bladder cancer

Studienleiter: D.Geijsen (Amsterdam), P.J. Goebell und O. Ott (Erlangen)